How A10521 changes current law

Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state · New York

How this bill changes current law

1 change

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

This bill amends 1 section(s) of the New York Consolidated Laws: Section 2500-a of the public health law.

  • Section 2500-a of the public health law

    (l) Late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2). (m) Mucopolysaccharidosis type IVA (MPS IVA). (n) Mucopolysaccharidosis type VI (MPS VI). (o) Mucopolysaccharidosis type VII (MPS VII). (p) Fabry. 4. The commissioner shall ensure tests are made available for all diseases and conditions designated pursuant to paragraphs (l), (m), (n), (o) and (p) of subdivision one of this section within twelve months of the effective date of such paragraphs. italics

    amended

Download the branded redline PDF

A print-ready, House Comparative-Print–style redline to forward to your team or leadership.

One email, no spam — used to send updates on bills like this.

View the full bill Permalink: https://www.oneclickpolitics.com/bills/106960-a10521/current-law